These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 38741396)
1. Evaluation of medication use and polypharmacy in postoperative cardiac patients: The clinical pharmacist's imperative in a public institute of Pakistan. Humza AU; Hameed A; Akbar MA; Ahmed I; Ali A; Bin Yousuf J Pak J Pharm Sci; 2024 Jan; 37(1):17-23. PubMed ID: 38741396 [TBL] [Abstract][Full Text] [Related]
2. Pharmacists' viewpoint towards their professional role in healthcare system: a survey of hospital settings of Pakistan. Khan N; McGarry K; Naqvi AA; Iqbal MS; Haider Z BMC Health Serv Res; 2020 Jul; 20(1):610. PubMed ID: 32615966 [TBL] [Abstract][Full Text] [Related]
3. Medication adherence among cardiac patients in Khartoum State, Sudan: a cross-sectional study. Awad A; Osman N; Altayib S Cardiovasc J Afr; 2017 Nov/Dec 23; 28(6):350-355. PubMed ID: 28345729 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of a collaborative care approach between general practitioners and clinical pharmacists in primary care community settings in elderly patients on polypharmacy in Slovenia: a cohort retrospective study reveals positive evidence for implementation. Stuhec M; Gorenc K; Zelko E BMC Health Serv Res; 2019 Feb; 19(1):118. PubMed ID: 30760276 [TBL] [Abstract][Full Text] [Related]
5. The role of the clinical pharmacist in the prevention of potential drug interactions in geriatric heart failure patients. Georgiev KD; Hvarchanova N; Georgieva M; Kanazirev B Int J Clin Pharm; 2019 Dec; 41(6):1555-1561. PubMed ID: 31595450 [TBL] [Abstract][Full Text] [Related]
6. Structured medication reviews in Parkinson's disease: pharmacists' views, experiences and needs - a qualitative study. Oonk NGM; Dorresteijn LDA; Te Braake E; Movig KLL; van der Palen J; Nijmeijer HW; van Kesteren ME; Bode C Ther Adv Drug Saf; 2024; 15():20420986241237071. PubMed ID: 38694547 [TBL] [Abstract][Full Text] [Related]
7. Prevalence and risk of potential cytochrome P450-mediated drug-drug interactions in older hospitalized patients with polypharmacy. Doan J; Zakrzewski-Jakubiak H; Roy J; Turgeon J; Tannenbaum C Ann Pharmacother; 2013 Mar; 47(3):324-32. PubMed ID: 23482734 [TBL] [Abstract][Full Text] [Related]
8. Doctors' perceptions, expectations and experience regarding the role of pharmacist in hospital settings of Pakistan. Khan N; McGarry K; Naqvi AA; Holden K Int J Clin Pharm; 2020 Apr; 42(2):549-566. PubMed ID: 32065340 [TBL] [Abstract][Full Text] [Related]
9. The role of the clinical pharmacist in reducing mortality in hospitalized cardiac patients: A prospective, nonrandomized controlled trial using propensity score methods. Zhai XB; Tian DD; Liu XY Int J Clin Pharmacol Ther; 2015 Mar; 53(3):220-9. PubMed ID: 25546163 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of pharmacist interventions and commonly used medications in the geriatric ward of a teaching hospital in Turkey: a retrospective study. Ertuna E; Arun MZ; Ay S; Koçak FÖK; Gökdemir B; İspirli G Clin Interv Aging; 2019; 14():587-600. PubMed ID: 30962679 [TBL] [Abstract][Full Text] [Related]
11. A clinical pharmacist-led integrated approach for evaluation of medication errors among medical intensive care unit patients. Aghili M; Neelathahalli Kasturirangan M JBI Evid Implement; 2021 Mar; 19(1):21-30. PubMed ID: 33570331 [TBL] [Abstract][Full Text] [Related]
12. Potential drug-drug interactions among pneumonia patients: do these matter in clinical perspectives? Noor S; Ismail M; Ali Z BMC Pharmacol Toxicol; 2019 Jul; 20(1):45. PubMed ID: 31349877 [TBL] [Abstract][Full Text] [Related]
14. Review of prescription medications in home-based older adults with stroke: a pilot study. Classen S; Meuleman J; Garvan C; Ried LD; Mann W; Asal N Res Social Adm Pharm; 2007 Mar; 3(1):104-22. PubMed ID: 17350560 [TBL] [Abstract][Full Text] [Related]
15. Risk of potential drug-drug interactions among Brazilian elderly: a population-based, cross-sectional study. Secoli SR; Figueras A; Lebrão ML; de Lima FD; Santos JL Drugs Aging; 2010 Sep; 27(9):759-70. PubMed ID: 20809665 [TBL] [Abstract][Full Text] [Related]
16. Prevalence of Polypharmacy and Potential Drug-Drug Interactions Associated with Risk Factors in the Era of HIV Integrase Inhibitors: A Prospective Clinical Study. Altunal LN; Yagcı Caglayık D; Ozel AS; Tukenmez Tigen E; Sili U; Erturk Sengel B; Aydın M; Korten V AIDS Patient Care STDS; 2023 Mar; 37(3):138-145. PubMed ID: 36812461 [TBL] [Abstract][Full Text] [Related]
17. Medication Appropriateness, Polypharmacy, and Drug-Drug Interactions in Ambulatory Elderly Patients with Cardiovascular Diseases at Tikur Anbessa Specialized Hospital, Ethiopia. Adem L; Tegegne GT Clin Interv Aging; 2022; 17():509-517. PubMed ID: 35464156 [TBL] [Abstract][Full Text] [Related]
18. The prevalence and severity of potential drug-drug interactions among adult polypharmacy patients at outpatient clinics in Jordan. Nusair MB; Al-Azzam SI; Arabyat RM; Amawi HA; Alzoubi KH; Rabah AA Saudi Pharm J; 2020 Feb; 28(2):155-160. PubMed ID: 32042253 [TBL] [Abstract][Full Text] [Related]
19. Impact of pharmacist interventions in older patients: a prospective study in a tertiary hospital in Germany. Cortejoso L; Dietz RA; Hofmann G; Gosch M; Sattler A Clin Interv Aging; 2016; 11():1343-1350. PubMed ID: 27713625 [TBL] [Abstract][Full Text] [Related]
20. Clinical medication reviews in elderly patients with polypharmacy: a cross-sectional study on drug-related problems in the Netherlands. Chau SH; Jansen AP; van de Ven PM; Hoogland P; Elders PJ; Hugtenburg JG Int J Clin Pharm; 2016 Feb; 38(1):46-53. PubMed ID: 26597955 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]